About HORIBA Medical

An extensive and comprehensive solution provider in in vitro diagnostics

HORIBA Medical provides an extensive and comprehensive line of hematology, hemostasis and clinical chemistry solutions (including analyzers, reagents and consumables) for use in in vitro diagnostic.

Proven quality and trustworthy performance have established widespread confidence in the HORIBA Medical brand.

Today, more than 30,000 laboratories are using HORIBA Medical’s solutions around the world.

Key figures

Over 1,230 employees
5 production centers (Japan, China, France, Brazil, India)
2 R&D centers (Japan, France)
More than 100 distributors
15 local/direct operations
More than 30,000 laboratories supplied worldwide

A global presence

Globally, our instrumentation has captured a significant portion of the world market with strength in France, Japan, U.K. and America. Distribution is handled through both a direct sales force and all of the major national and regional distributors. Today, present in near 150 countries on all five continents, with internationally recognized instruments and a leader’s ranking in most markets, HORIBA Medical is a world leader on the Hematology market. The strength of its distribution network coupled with its experience allows HORIBA Medical to operate efficiently in international markets.

Expertise at the customer's service

HORIBA Medical has over 1,230 employees across its sites and subsidiaries. In 2022, it produced nearly 7,000 instruments and over 9,000 tons of reagents. Our direct team of in-house Technical Service Representatives along with nationwide coverage of Field Service Representatives offers un-paralleled remote and on-site service. With the added value of a direct team of Systems Installation Specialists, these med-tech's are a key component to a successful installation and on-going support. HORIBA Medical also benefits from technologies patented by the HORIBA Group and the synergies between all its research centers throughout the world. Since it was incorporated into the HORIBA Group in 1996, the Medical segment sales have continued to grow exponentially to reach 226 MUSD in 2022.

Fully mobilized to meet tomorrow’s major challenges

HORIBA Medical instrument production site

Providing reliable, high-quality devices that are trusted by our customers and meet their expectations: such is the ambition that drives the daily work of our teams, who are fully committed towards developing healthcare solutions for tomorrow. HORIBA Medical has earned an international reputation for its high standards of innovation. The flexibility of its production units and the recognized technological creativity of its R&D centers give it a real edge in the development of evolving products in line with market needs.

Our ambition: anticipate quality standards

HORIBA Medical Innovation and Development Center

Faced with ever more demanding quality standards, HORIBA Medical deploys a rigorous and inventive policy to meet and respond to these by anticipating trends. It is audacious in its technological creativity while always remaining faithful to its commitment to the environment. The company aims to maintain the confidence of its customers and strengthen its position on a global scale.

Our commitment: promote eco-design

HORIBA Medical is extremely aware of current sustainable development issues and is committed to reducing the environmental footprint of its activities, notably by promoting the eco-design of its products. For example, this implies designing equipment that is more economical in terms of electricity and reagents; devices that are increasingly compact and light; total dematerialization of patient results; optimization of logistics; development of more eco-responsible reagents...

PDF

11.35 MB